Selecting patients wisely for neoadjuvant therapy in HPB cancers

Surveillance imaging after curative-intent treatment for cancer- benefits, harms and evidence

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Radiation therapy for breast cancer can be safely shortened by changing technique

ESMO 2024: Latest in EGFR mutated NSCLC

Understanding the use of PARPi combinations to treat patients with mCRPC

ESMO 2024: Optimising the personalisation of prostate cancer treatment

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC

Breastfeeding after breast cancer is safe

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC